Abiopharma

News list

HARVARD BIOSCIENCE, INC. (HBIO)

SEC News
March 12, 2026, 11:30 UTC

(99% Positive) HARVARD BIOSCIENCE, INC. (HBIO) Reports Q1 2026 Financial Results

Full text

News bot March 12, 2026, 11:33 a.m.

📋 HARVARD BIOSCIENCE, INC. (HBIO) - Financial Results

Filing Date: 2026-03-12

Accepted: 2026-03-12 07:30:29

Event Type: Financial Results

Event Details:

HARVARD BIOSCIENCE, INC. (HBIO) Reports the reporting period Financial Results HARVARD BIOSCIENCE, INC. (HBIO) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: 5093
Net Income: $23,735
EPS: (0.00
Cash and equivalents: (8,614

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2025	2024	Change ($)	Change (%)
Revenue	24.56K	24.56K	$0.00	+0.00%
Other Expense Interest Expense	1.18K	1.18K	$0.00	+0.00%
Current Portion Of Longterm Debt Other Long Term Liabilities	8.51K	8.51K	$0.00	+0.00%
Interest Expense	1.66K	1.66K	$0.00	+0.00%
Net Loss	2.85K	2.85K	$0.00	+0.00%
Term Loans	40.00K	40.00K	$0.00	+0.00%

💼 Business Developments:

Partnership: Not available
Acquisition
Licensing: Not available
Regulatory Approval: Not available
Executive Changes: Not available

Structured Data:

Company Name: HARVARD BIOSCIENCE, INC.
Ticker Symbol: HBIO